Karyopharm Therapeutics Inc. (KPTIQ) shareholders
KPTIQPharmaceutical PreparationsFiscal year ends December 31Also trades as KPTI
Share price
Not available yet
Price, market cap and P/E appear here once daily prices are connected.
Ownership
Who owns Karyopharm Therapeutics's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 21 sales
Net sold $351.42K
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Peter Kolchinsky Joint filing with RA Capital Management, L.P. (9.90%), Rajeev Shah (9.90%) and 1 more | 2,302,504 | 9.90% | 13G (passive) amendment | Jun 30, 2026 |
| Rajeev Shah Joint filing with RA Capital Management, L.P. (9.90%), Peter Kolchinsky (9.90%) and 1 more | 2,078,913 | 9.90% | 13G (passive) | Mar 26, 2026 |
| Affinity Asset Advisors, LLC Joint filing with Michael Cho (8.60%) | 2,073,517 | 8.60% | 13G (passive) amendment | Mar 31, 2026 |
| Commodore Capital Master LP Joint filing with Commodore Capital LP (9.90%), Robert Egen Atkinson (9.90%) and 1 more | 1,950,000 | 9.90% | 13G (passive) | Mar 26, 2026 |
| Michael Cho Joint filing with Affinity Asset Advisors, LLC (8.60%) | 1,713,092 | 8.60% | 13G (passive) amendment | Jan 22, 2026 |
| Opaleye Management Inc. Joint filing with Opaleye, L.P. (9.48%), James Silverman (9.48%) | 1,569,002 | 9.48% | 13G (passive) | Oct 10, 2025 |
| T. Rowe Price Investment Management, Inc. | 1,539,147 | 6.60% | 13G (passive) amendment | May 31, 2026 |
| Robert Atchinson Joint filing with Adage Capital Management, L.P. (6.78%), Phillip Gross (6.78%) | 1,536,736 | 6.78% | 13G (passive) amendment | Jun 30, 2026 |
| Israel A. Englander Joint filing with Integrated Core Strategies (US) LLC (5.70%), Millennium Management LLC (5.70%) and 1 more | 1,297,297 | 5.70% | 13G (passive) | Aug 31, 2026 |
| BlackRock, Inc. | 1,266,084 | 5.60% | 13G (passive) | Jun 30, 2026 |
| Affinity Healthcare Fund, LP Joint filing with Affinity Asset Advisors, LLC (7.83%) | 664,224 | 7.83% | 13G (passive) | Apr 3, 2025 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | Latest filing |
|---|---|---|---|
| Richard A. Paulson | President and CEO, Director | 269,747 | May 15, 2026 |
| Kristin Abate | Chief Accounting Officer | 18,616 | Oct 19, 2026 |
| Stuart Poulton | EVP, Chief Development Officer | 94,632 | Jul 30, 2026 |
| Reshma Rangwala | EVP & Chief Medical Officer | 56,829 | May 15, 2026 |
| Sohanya Roshan Cheng | EVP & Chief Commercial Officer | 107,940 | May 15, 2026 |
| Michael Mano | EVP, CLO&Secretary | 94,398 | May 15, 2026 |
| Lori Macomber | EVP, CFO & Treasurer | 85,105 | Feb 4, 2026 |
| Christy J. Oliger | Director | 15,508 | May 26, 2026 |
| Chen Schor | Director | 15,508 | May 26, 2026 |
| Barry E. Greene | Director | 16,415 | May 26, 2026 |
| Garen G. Bohlin | Director | 18,517 | May 26, 2026 |
| Deepika Pakianathan | Director | 15,508 | May 26, 2026 |
| Zhen Su | Director | 15,508 | May 26, 2026 |
| Mansoor Raza Mirza | Director | 17,121 | May 29, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Kristin Abate Chief Accounting Officer | Oct 16, 2026 | Sale | −4,788 | $0.34 | $1.65K | 18,616 |
| Kristin Abate Chief Accounting Officer | Oct 1, 2026 | Sale | −378 | $1.19 | $450 | 23,404 |
| Kristin Abate Chief Accounting Officer | Sep 1, 2026 | Sale | −19 | $2.02 | $38 | 23,782 |
| Stuart Poulton EVP, Chief Development Officer | Jul 28, 2026 | Sale | −189 | $7.10 | $1.34K | 94,632 |
| Christy J. Oliger Director | May 21, 2026 | Award | +15,508 | – | – | 15,508 |
| Garen G. Bohlin Director | May 21, 2026 | Award | +15,508 | – | – | 18,517 |
| Zhen Su Director | May 21, 2026 | Award | +15,508 | – | – | 15,508 |
| Chen Schor Director | May 21, 2026 | Award | +15,508 | – | – | 15,508 |
| Deepika Pakianathan Director | May 21, 2026 | Award | +15,508 | – | – | 15,508 |
| Barry E. Greene Director | May 21, 2026 | Award | +15,508 | – | – | 16,415 |
| Stuart Poulton EVP, Chief Development Officer | May 14, 2026 | Sale | −403 | $9.50 | $3.83K | 94,821 |
| Kristin Abate Chief Accounting Officer | May 14, 2026 | Sale | −53 | $9.50 | $504 | 23,801 |
| Michael Mano EVP, CLO&Secretary | May 14, 2026 | Sale | −266 | $9.50 | $2.53K | 94,398 |
| Richard A. Paulson President and CEO, Director | May 14, 2026 | Sale | −2,203 | $9.50 | $20.93K | 269,747 |
| Reshma Rangwala EVP & Chief Medical Officer | May 14, 2026 | Sale | −408 | $9.50 | $3.88K | 56,829 |
| Sohanya Roshan Cheng EVP & Chief Commercial Officer | May 14, 2026 | Sale | −324 | $9.50 | $3.08K | 107,940 |
| Stuart Poulton EVP, Chief Development Officer | May 13, 2026 | Award | +896 | – | – | 95,224 |
| Kristin Abate Chief Accounting Officer | May 13, 2026 | Award | +121 | – | – | 23,854 |
| Michael Mano EVP, CLO&Secretary | May 13, 2026 | Award | +700 | – | – | 94,664 |
| Richard A. Paulson President and CEO, Director | May 13, 2026 | Award | +4,920 | – | – | 271,950 |
| Reshma Rangwala EVP & Chief Medical Officer | May 13, 2026 | Award | +947 | – | – | 57,237 |
| Sohanya Roshan Cheng EVP & Chief Commercial Officer | May 13, 2026 | Award | +947 | – | – | 108,264 |
| Reshma Rangwala EVP & Chief Medical Officer | Apr 21, 2026 | Sale | −449 | $8.94 | $4.01K | 56,290 |
| Stuart Poulton EVP, Chief Development Officer | Mar 2, 2026 | Sale | −5,101 | $9.41 | $48.00K | 94,328 |
| Kristin Abate Chief Accounting Officer | Mar 2, 2026 | Sale | −559 | $9.41 | $5.26K | 22,063 |
| Michael Mano EVP, CLO&Secretary | Mar 2, 2026 | Sale | −3,526 | $9.41 | $33.18K | 93,964 |
| Richard A. Paulson President and CEO, Director | Mar 2, 2026 | Sale | −12,361 | $9.41 | $116.32K | 267,030 |
| Sohanya Roshan Cheng EVP & Chief Commercial Officer | Mar 2, 2026 | Sale | −4,604 | $9.41 | $43.32K | 107,317 |
| Reshma Rangwala EVP & Chief Medical Officer | Mar 2, 2026 | Sale | −5,066 | $9.41 | $47.67K | 56,739 |
| Stuart Poulton EVP, Chief Development Officer | Feb 17, 2026 | Sale | −378 | $8.63 | $3.26K | 99,429 |
| Richard A. Paulson President and CEO, Director | Feb 5, 2026 | Award | +81,060 | – | – | 279,391 |
| Lori Macomber EVP, CFO & Treasurer | Feb 3, 2026 | Sale | −1,626 | $6.30 | $10.24K | 85,105 |
| Lori Macomber EVP, CFO & Treasurer | Jan 31, 2026 | Award | +32,415 | – | – | 86,731 |
| Sohanya Roshan Cheng EVP & Chief Commercial Officer | Jan 31, 2026 | Award | +32,415 | – | – | 111,921 |
| Michael Mano EVP, CLO&Secretary | Jan 31, 2026 | Award | +32,415 | – | – | 97,490 |
| Stuart Poulton EVP, Chief Development Officer | Jan 31, 2026 | Award | +32,415 | – | – | 99,807 |
| Reshma Rangwala EVP & Chief Medical Officer | Jan 31, 2026 | Award | +32,415 | – | – | 61,805 |
| Kristin Abate Chief Accounting Officer | Jan 28, 2026 | Sale | −50 | $7.03 | $352 | 22,622 |
| Kristin Abate Chief Accounting Officer | Jan 27, 2026 | Award | +92 | – | – | 22,672 |
| Kristin Abate Chief Accounting Officer | Jan 21, 2026 | Sale | −265 | $5.96 | $1.58K | 22,580 |
| Richard A. Paulson President and CEO, Director | Oct 15, 2025 | Award | +114,285 | – | – | 198,331 |
| Michael Mano SVP, General Counsel&Secretary | Oct 15, 2025 | Award | +43,650 | – | – | 65,075 |
| Lori Macomber EVP, CFO & Treasurer | Oct 15, 2025 | Award | +43,650 | – | – | 54,316 |
| Kristin Abate Chief Accounting Officer | Oct 15, 2025 | Award | +12,799 | – | – | 22,845 |
| Stuart Poulton EVP, Chief Development Officer | Oct 15, 2025 | Award | +39,682 | – | – | 67,392 |
| Sohanya Roshan Cheng EVP & Chief Commercial Officer | Oct 15, 2025 | Award | +43,650 | – | – | 79,506 |
| Kristin Abate Chief Accounting Officer | Oct 1, 2025 | Sale | −362 | $6.30 | $2.28K | 10,046 |
| Sohanya Roshan Cheng EVP & Chief Commercial Officer | Sep 15, 2025 | Sale | −325 | $6.43 | $2.09K | 35,856 |
| Richard A. Paulson President and CEO, Director | Sep 15, 2025 | Sale | −1,257 | $6.43 | $8.08K | 84,046 |
| Michael Mano SVP, General Counsel&Secretary | Sep 15, 2025 | Sale | −234 | $6.43 | $1.50K | 21,425 |
| Kristin Abate Chief Accounting Officer | Sep 15, 2025 | Sale | −23 | $6.43 | $148 | 10,408 |
| Stuart Poulton EVP, Chief Development Officer | Sep 15, 2025 | Sale | −401 | $6.43 | $2.58K | 27,710 |
| Reshma Rangwala EVP & Chief Medical Officer | Sep 15, 2025 | Sale | −408 | $6.43 | $2.62K | 29,390 |
| Sohanya Roshan Cheng EVP & Chief Commercial Officer | Sep 12, 2025 | Award | +945 | – | – | 36,181 |
| Richard A. Paulson President and CEO, Director | Sep 12, 2025 | Award | +2,800 | – | – | 85,303 |
| Michael Mano SVP, General Counsel&Secretary | Sep 12, 2025 | Award | +612 | – | – | 21,659 |
| Kristin Abate Chief Accounting Officer | Sep 12, 2025 | Award | +46 | – | – | 10,431 |
| Stuart Poulton EVP, Chief Development Officer | Sep 12, 2025 | Award | +888 | – | – | 28,111 |
| Reshma Rangwala EVP & Chief Medical Officer | Sep 12, 2025 | Award | +945 | – | – | 29,798 |
| Kristin Abate Chief Accounting Officer | Sep 3, 2025 | Sale | −12 | $6.78 | $81 | 9,463 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
See a number that looks wrong?